English
Polski
Español
українська
Frailty and the risk of fractures
Is frailty associated with a risk of fractures? Is quantitative assessment of frailty possible?
2018-12-03
Is frailty associated with a risk of fractures? Is quantitative assessment of frailty possible?
When should we use plasmapheresis in rheumatologic emergencies?
How can we predict osteoporotic fractures in an elderly patient? What are the best tools to diagnose osteoporosis that help in decision-making?
Can biologic treatment be restarted in a patient who developed tuberculosis (TB) while on anti–tumor necrosis factor (TNF) treatment? Can we use anti-TNF agents again in such patients?
How should we manage a patient with latent tuberculosis (TB) infection before starting biologic treatment?
Is osteoporosis caused by long-term use of strong opioids a significant clinical problem?
What is the risk of tuberculosis (TB) during biologic treatment with agents other than tumor necrosis factor (TNF)–alpha inhibitors?
What should be the initial management in rheumatologic emergencies? Which patients should be transported to the ICU?
What is the actual risk of tuberculosis during biologic therapy of rheumatic diseases? Which class of drugs carries the highest risk of TB?
When should we start pharmacological treatment of osteoporosis?
